Search Results

You are looking at 1 - 2 of 2 items for :

  • »Framingham« rizik skor x
Clear All
Open access

Snežana Jovičić, Svetlana Ignjatović and Nada Majkić-Singh

. 2003; 362 : 1776-7. D'Agostino RB, Grundy SM, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic group investigation. JAMA. 2001; 286 : 180-7. Zamaklar M. Konsenzus konferencija o promeni referentnih vrednosti lipida i ciljnim vrednostima lečenja lipidskih poremećaja. Jugoslov Med Biohem. 2005; 24 : 299-300.

Open access

Snežana Jovičić

inhibits three steps in the formation of mildly oxidized low density lipoprotein. J Lipid Res 2000; 41: 1481-508. Vega GL, Grundy SM. Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease. Curr Opin Lipidol 1996; 7: 209-16. Schaefer EJ, Lamon-Fava S, Ordovas JM, Cohn SD, Schaefer MM, Castelli WP, et al. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res 1994